Antithrombosis management in community-dwelling elderly: improving safety.
Thrombus-related conditions are increasing in the elderly population. This article provides an overview of thrombus formation and describes the various pharmacologic options for prevention. Thromboprophylaxis requires an assessment of the risks and benefits of treatment so that catastrophic bleeding does not result. A practice model, the "S.A.F.E. Triad" is proposed to provide a framework for addressing safety concerns, while algorithms assist with decision-making.
Advocate Health Care, and Rush University, Chicago, IL, USA.
Denise
D
Bockwoldt
D057179:Advanced Practice Nursing / Q000193:education / Q000458:organization & administration*; D000368:Aged; D000465:Algorithms; D000925:Anticoagulants / Q000627:therapeutic use; D016903:Drug Monitoring / Q000451:nursing; D011307:Drug Prescriptions / Q000451:nursing*; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D015577:Geriatric Assessment; D005851:Geriatric Nursing / Q000193:education / Q000458:organization & administration*; D006801:Humans; D016294:Models, Nursing; D024802:Nurse's Role; D009730:Nursing Assessment; D010353:Patient Education as Topic; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors; D017751:Safety Management / Q000458:organization & administration*; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology / Q000451:nursing
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors